MedPath

NOVOMIX 30

NOVOMIX 30

Approved
DIN Number

02265435

Drug Class

Human

Market Date

Sep 12, 2005

Company
HC

Novo Nordisk Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02265435
AIG Number0252426004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
A10AD05 INSULIN ASPART
Product Specifications
Dosage FormSuspension
Route of AdministrationSubcutaneous
AHFS Classification68:20.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

INSULIN ASPARTActive
Strength: 30 UNIT / ML
Monograph: INSULIN ASPART
INSULIN ASPART PROTAMINEActive
Strength: 70 UNIT / ML
Monograph: INSULIN ASPART PROTAMINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.